Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data

Structure's pill is part of the same class of drugs as Novo Nordisk's blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy.

Source: CNBC

Continue reading...